Phase II trial of etoposide in APUD tumors Journal Article


Authors: Kelsen, D.; Fiore, J.; Heelan, R.; Cheng, E.; Magill, G.
Article Title: Phase II trial of etoposide in APUD tumors
Abstract: Thirty-three patients with advanced, metastatic APUD tumors (islet cell, carcinoid, or medullary carcinomas of the thyroid) were treated with etoposide as a single agent. Of 29 evaluable patients, four (14%) had partial responses (95% confidence limits, 1%-26%). Toxic effects seen were those previously reported for etoposide as a single agent. Etoposide has activity in APUD tumors; further studies with this agent are indicated.
Keywords: adult; cancer chemotherapy; clinical article; aged; middle aged; advanced cancer; drug efficacy; skin toxicity; metastasis; etoposide; nausea; vomiting; carcinoembryonic antigen; calcitonin; gastrointestinal toxicity; carcinoid; thyroid neoplasms; drug therapy; small intestine; alopecia; carcinoid tumor; adverse drug reaction; therapy; intravenous drug administration; pancreas islet cell carcinoma; pancreas islet cell tumor; endocrine system; thyroid medullary carcinoma; bone marrow depression; gastrins; drug evaluation; intoxication; adenoma, islet cell; humans; human; male; female; priority journal; hydroxyindoleacetic acid; apudoma; blood and hemopoietic system
Journal Title: Cancer Treatment Reports
Volume: 71
Issue: 3
ISSN: 0361-5960
Publisher: National Cancer Institute  
Date Published: 1987-03-01
Start Page: 305
End Page: 307
Language: English
PUBMED: 2434226
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 5 February 2021 -- Source: Scopus
Citation Impact
MSK Authors
  1. David P Kelsen
    537 Kelsen
  2. Robert T Heelan
    140 Heelan
  3. Gordon B. Magill
    30 Magill
  4. Edgar Cheng
    16 Cheng